Understanding barriers to fertility care for young cancer patients
Fertility legislation and unmet needs: Exploring intervenable barriers for quality oncofertility care among adolescent and young adult cancer patients
This study is looking at the difficulties young cancer patients face when it comes to understanding their options for preserving their fertility after treatment, and it aims to make sure they get clear information about these options from their doctors.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11080782 on NIH RePORTER |
What this research studies
This research investigates the challenges faced by adolescent and young adult cancer patients regarding fertility preservation options after treatment. It aims to identify the barriers that prevent effective communication about fertility risks and preservation methods among healthcare providers and patients. By examining factors at multiple levels, including patient, provider, and policy influences, the study seeks to improve oncofertility care for this vulnerable population. The goal is to ensure that young cancer patients receive comprehensive information about their fertility options during their treatment journey.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescent and young adult cancer patients aged 15-39 who are concerned about the impact of cancer treatment on their fertility.
Not a fit: Patients outside the age range of 15-39 or those not undergoing gonadotoxic cancer treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to fertility preservation options for young cancer patients, helping them maintain their reproductive health.
How similar studies have performed: Previous research has indicated that addressing barriers to oncofertility care can significantly improve patient outcomes, suggesting that this approach has potential for success.
Where this research is happening
Boston, United States
- Dana-Farber Cancer Inst — Boston, United States (Active)
Researchers
- Principal investigator: Stal, Julia — Dana-Farber Cancer Inst
- Study coordinator: Stal, Julia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.